Physician

Julie O'Keefe, MD

According to 2025 Medicare claims, Julie O'Keefe, MD (NPI: 1013078880) practices endocrinology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from Calvert, MD. This provider's primary affiliated billing organization is CALVERT INTERNAL MEDICINE GROUP PA (NPI: 1174682298; TIN: 521365400) and primary practice location at 20678-3492.

O'Keefe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 647 traditional Medicare patients, billed 19,334 HCPCS/CPT codes, and received $413,158 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,737 prescription claims across 394 beneficiaries totaling $1,600,453 in drug costs, led by Trulicity (Dulaglutide). DME data shows 1,028 claims. Open Payments data shows 1 records totaling $56. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $154,980 to $413,158. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $515,861 to $1,600,453. For DME billing, reported payments moved sharply higher in recent years, from $28,669 to $292,040.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	509	6,960	$154,980
2016	519	7,903	$169,362
2017	514	7,386	$167,694
2018	495	7,682	$164,820
2019	531	10,069	$217,445
2020	529	11,211	$236,174
2021	563	12,133	$284,885
2022	598	13,842	$313,192
2023	679	14,135	$339,165
2024	647	19,334	$413,158

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	209	2,190	$515,861
2016	229	2,301	$677,499
2017	256	2,472	$827,681
2018	266	2,474	$931,147
2019	273	2,554	$953,653
2020	270	2,798	$1,080,841
2021	276	2,860	$1,287,373
2022	276	2,923	$1,352,897
2023	274	2,952	$1,521,087
2024	394	3,737	$1,600,453

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	362	856	$45,413
2016	365	917	$57,327
2017	320	712	$67,552
2018	294	878	$98,636
2019	282	971	$128,345
2020	261	1,042	$151,827
2021	238	1,244	$199,089
2022	246	1,345	$227,339
2023	263	1,474	$266,103
2024	226	1,028	$300,344

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	451	930	$92
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	341	531	$12
83036	Hemoglobin a1c level	237	471	$9
36415	Insertion of needle into vein for collection of blood sample	361	647	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	244	324	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trulicity	Dulaglutide	135	7,534	$243,244
Mounjaro	Tirzepatide	159	6,654	$227,876
Ozempic	Semaglutide	97	6,578	$210,075
Jardiance	Empagliflozin	140	9,790	$168,292
Farxiga	Dapagliflozin Propanediol	89	6,150	$109,647

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	100	547	$210,044
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	13	53	$25,119
E0784	External ambulatory infusion pump, insulin	Y	N/R	73	$23,618
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	31	89	$21,292
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	35	$10,823

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$56	Tandem Diabetes Care, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Julie O'Keefe, MD?

Tedicare shows public-source Medicare data for Julie O'Keefe, MD (NPI 1013078880), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Julie O'Keefe, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Julie O'Keefe, MD?

Julie O'Keefe, MD is linked to CALVERT INTERNAL MEDICINE GROUP PA (billing NPI 1174682298) in the available physician profile data.

Does Julie O'Keefe, MD have Open Payments data?

Julie O'Keefe, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.